These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6224542)

  • 41. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of normal and dystrophic muscles to increased functional demand.
    Dangain J; Vrbová G
    Exp Neurol; 1986 Dec; 94(3):796-801. PubMed ID: 3780923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of irradiation on regeneration in dystrophic mouse leg muscles.
    Wirtz P; Loermans H; Rutten E
    Br J Exp Pathol; 1982 Dec; 63(6):671-9. PubMed ID: 7150513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of muscular potentials evoked by single shocks to sciatic nerves and their different changes due to repetitive stimulation at a moderate frequency in dystrophic and normal mice.
    Watanabe K; Uramoto I; Totsuka T
    Electromyogr Clin Neurophysiol; 1983; 23(1-2):103-15. PubMed ID: 6301805
    [No Abstract]   [Full Text] [Related]  

  • 45. Passive mechanical properties of maturing extensor digitorum longus are not affected by lack of dystrophin.
    Wolff AV; Niday AK; Voelker KA; Call JA; Evans NP; Granata KP; Grange RW
    Muscle Nerve; 2006 Sep; 34(3):304-12. PubMed ID: 16770793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
    McIntosh LM; Pernitsky AN; Anderson JE
    Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acetylcholine sensitivity in replicating satellite cells.
    Eusebi F; Molinaro M
    Muscle Nerve; 1984; 7(6):488-92. PubMed ID: 6543903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
    Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
    Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse.
    Souccar C; Gonçalo Mdo C; Buck Hde S; Lima-Landman MT; Lapa AJ
    Neuromuscul Disord; 2005 Jan; 15(1):48-56. PubMed ID: 15639121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of genetically dystrophic animals in chemotherapy trials and application of serotonin antagonists as antidystrophic drugs.
    Barnard EA; Barnard PJ
    Ann N Y Acad Sci; 1979; 317():374-99. PubMed ID: 289319
    [No Abstract]   [Full Text] [Related]  

  • 52. Muscle transplantation in normal and dystrophic animals.
    Dubowitz V; Neerunjun J
    J Physiol; 1973 Jun; 231(2):61P. PubMed ID: 4146463
    [No Abstract]   [Full Text] [Related]  

  • 53. Restoration of functional continuity in dystrophic murine muscle after crushing.
    Stuart A; McComas AJ; Dean D
    Exp Neurol; 1983 Jul; 81(1):153-7. PubMed ID: 6861943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parabiotic reinnervation in normal and dystrophic mice. Part 1. Muscle weight and physiological studies.
    Montgomery A
    J Neurol Sci; 1975 Nov; 26(3):401-23. PubMed ID: 1185240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiological estimates of the sizes and the numbers of motor units in soleus muscles of dystrophic mice.
    Law PK; Caccia MR
    J Neurol Sci; 1975 Feb; 24(2):251-6. PubMed ID: 1113137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Active state of normal and dystrophic mouse muscle.
    Sabbadini RA; Baskin RJ
    Am J Physiol; 1976 Apr; 230(4):1138-47. PubMed ID: 1267011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ontogenetic aspects of changes in muscular potentials at medial gastrocnemius muscles of dystrophic mice due to prolonged stimulation.
    Watanabe K; Uramoto I; Totsuka T
    J Neurol Sci; 1984 Oct; 66(1):59-66. PubMed ID: 6520613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Denervation effects on dystrophic and normal muscles and the etiology of dystrophy.
    Zeman RJ; Sandow A
    Ann N Y Acad Sci; 1979; 317():171-86. PubMed ID: 289310
    [No Abstract]   [Full Text] [Related]  

  • 59. Intracellular activity of potassium in normal and dystrophic skeletal muscle from C57BL/6J mice.
    Shalton PM; Wareham AC
    Exp Neurol; 1981 Dec; 74(3):673-87. PubMed ID: 7308365
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term peripheral nerve and muscle recordings from normal and dystrophic mice.
    Milner TE; Hoffer JA
    J Neurosci Methods; 1987 Jan; 19(1):37-45. PubMed ID: 3821159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.